GO:0047621 acylpyruvate hydrolase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0047621 acylpyruvate hydrolase activity catalyzes the hydrolysis of a 3-acylpyruvate to a carboxylate and pyruvate.
• The human enzyme FAHD1 (fumarylacetoacetate hydrolase domain-containing protein 1) is the best-characterized acylpyruvase, localizing to mitochondria.
• FAHD1 is bi-functional, acting as both an acylpyruvate hydrolase and an oxaloacetate decarboxylase.
• Structural studies reveal a conserved hydrolase fold with a catalytic triad and a binuclear metal center in some homologs.
• Dysregulation of FAHD1 has been linked to metabolic reprogramming and cancer, making it a potential therapeutic target.
• CRISPR knockout, knock-in, and overexpression models are essential to dissect the physiological roles of acylpyruvate hydrolase activity.
Description
Acylpyruvate hydrolase activity (GO:0047621) is a molecular function that catalyzes the hydrolysis of 3-acylpyruvate derivatives into pyruvate and a carboxylate. This enzymatic activity is critical for the breakdown of various acylpyruvate intermediates generated during amino acid and xenobiotic metabolism. In humans, the enzyme FAHD1 (fumarylacetoacetate hydrolase domain-containing protein 1) was identified as a mitochondrial acylpyruvase, linking this activity to central carbon metabolism and mitochondrial homeostasis. The importance of acylpyruvate hydrolase activity extends beyond basic metabolism; it is implicated in cellular responses to oxidative stress and metabolic diseases. Understanding its mechanism and regulation is essential for developing targeted therapies. This article provides a comprehensive overview of GO:0047621, covering its definition, catalytic mechanism, key genes, disease associations, and research methodologies, with a focus on CRISPR-based models for functional studies.
acylpyruvate hydrolase activity At A Glance
| GO ID | GO:0047621 |
|---|---|
| GO term | acylpyruvate hydrolase activity |
| Ontology | molecular_function |
| Synonym | 3-acylpyruvate acylhydrolase activity |
| Major function | Catalysis of the hydrolysis of 3-acylpyruvate to carboxylate and pyruvate |
| EC number | 3.7.1.- |
| Reaction | a 3-acylpyruvate + H2O = a carboxylate + pyruvate |
| Substrates | 3-acylpyruvate derivatives |
| Products | carboxylate, pyruvate |
What Is GO:0047621?
Acylpyruvate hydrolase activity (GO:0047621) is defined as the catalysis of the reaction: a 3-acylpyruvate + H2O = a carboxylate + pyruvate. This activity belongs to the hydrolase class of enzymes, specifically acting on carbon-carbon bonds in acylpyruvate substrates. The term is also known as 3-acylpyruvate acylhydrolase activity. It is a molecular function that contributes to various metabolic pathways, including the degradation of aromatic compounds and amino acids.
Why Is acylpyruvate hydrolase activity Important in Cell Biology?
Acylpyruvate hydrolase activity is important because it participates in key metabolic pathways that regulate energy production and detoxification. In humans, the enzyme FAHD1, which exhibits this activity, is involved in mitochondrial metabolism and has been linked to aging and cancer. Defects in acylpyruvate hydrolase activity can lead to the accumulation of toxic intermediates, contributing to metabolic disorders. Furthermore, this activity is a potential target for antimicrobial and anticancer therapies, as it is present in bacteria and human mitochondria. Studying GO:0047621 helps elucidate fundamental biochemical processes and provides insights into disease mechanisms.
• Critical for the degradation of acylpyruvate intermediates in amino acid metabolism.
• FAHD1, the human acylpyruvase, regulates mitochondrial function and oxidative stress responses.
• Altered FAHD1 expression is associated with cancer progression and metabolic reprogramming.
• Bacterial acylpyruvate hydrolases are involved in the degradation of aromatic compounds, with biotechnological potential.
• The activity is essential for the nonphosphorylated L-rhamnose pathway in bacteria.
• Provides a model for studying enzyme promiscuity and bi-functionality.
• Potential target for developing inhibitors against pathogenic bacteria.
• Contributes to the understanding of inherited metabolic diseases.
• Enables the design of CRISPR screens to identify synthetic lethal interactions.
• Facilitates structural biology studies on hydrolase mechanisms.
What Happens During acylpyruvate hydrolase activity?
Substrate Binding and Recognition
In simple terms: The enzyme grabs the 3-acylpyruvate molecule and positions it for cleavage.
The first step in acylpyruvate hydrolase activity involves the specific binding of a 3-acylpyruvate substrate to the enzyme's active site. Structural studies of FAHD1 have revealed a conserved hydrolase fold that accommodates the acylpyruvate moiety through hydrogen bonding and hydrophobic interactions. The substrate's acyl group is oriented towards the catalytic residues, while the pyruvate portion is stabilized by a metal center in some homologs. This precise binding ensures that only 3-acylpyruvate derivatives are processed, contributing to the enzyme's substrate specificity.
Catalytic Hydrolysis
In simple terms: Water is used to split the molecule into two products.
Upon substrate binding, a water molecule is activated by a catalytic triad (typically comprising a nucleophile, an acid, and a base) to attack the carbonyl carbon of the acyl group. This leads to the formation of a tetrahedral intermediate, which subsequently collapses to release the carboxylate product and a pyruvate molecule. In FAHD1, the catalytic mechanism is facilitated by a binuclear metal center that stabilizes the transition state and lowers the activation energy. The reaction is highly efficient and stereospecific, ensuring the production of pyruvate, a key metabolic intermediate.
Product Release and Enzyme Regeneration
In simple terms: The products leave, and the enzyme is ready for another round.
After hydrolysis, the carboxylate and pyruvate products are released from the active site. The enzyme undergoes conformational changes to reset its active site for subsequent catalytic cycles. In FAHD1, product release is thought to be facilitated by the dynamic nature of the active site loop, which opens to allow product exit. The released pyruvate can then enter central metabolic pathways such as the TCA cycle, while the carboxylate may be further metabolized or excreted. This step is crucial for maintaining metabolic flux and preventing product inhibition.
Bi-functional Catalysis and Regulation
In simple terms: Some enzymes can do two different jobs, and their activity is tightly controlled.
FAHD1 exhibits bi-functionality, acting as both an acylpyruvate hydrolase and an oxaloacetate decarboxylase. This dual activity is regulated by substrate availability and post-translational modifications. For instance, acetylation of FAHD1 has been shown to modulate its enzymatic activity, linking it to cellular metabolic states. Additionally, the expression of FAHD1 is regulated at the transcriptional level by factors such as PGC-1α, which controls mitochondrial biogenesis. This regulation ensures that acylpyruvate hydrolase activity is matched with cellular demands for pyruvate and energy production.
Key Genes Involved in GO:0047621 acylpyruvate hydrolase activity
The following genes and proteins are directly associated with acylpyruvate hydrolase activity (GO:0047621) based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| FAHD1 | Human acylpyruvate hydrolase; also oxaloacetate decarboxylase | Mitochondrial metabolism, cancer, aging |
| FAHD1 (mouse) | Mouse homolog of FAHD1 | Model organism studies of FAHD1 function |
| L-DDRA | L-2,4-diketo-3-deoxyrhamnonate hydrolase from bacteria | Nonphosphorylated L-rhamnose pathway |
| HpcE | Putative acylpyruvate hydrolase in aromatic degradation | Bacterial metabolism of pyridine derivatives |
| HpcH | 4-hydroxy-2-oxopentanoate aldolase | Adjacent pathway in pyridine metabolism |
| HmgA | Homogentisate 1,2-dioxygenase | Aromatic ring cleavage |
| HmgB | Fumarylacetoacetate hydrolase | Tyrosine degradation |
| Fah | Fumarylacetoacetate hydrolase | Tyrosinemia type I model |
| Pgc-1α | Transcriptional coactivator | Regulates FAHD1 expression |
| SIRT3 | Mitochondrial deacetylase | May regulate FAHD1 acetylation |
| ACAT1 | Acetyl-CoA acetyltransferase | Provides acetyl-CoA for acetylation |
| PDH | Pyruvate dehydrogenase | Links pyruvate to TCA cycle |
| PC | Pyruvate carboxylase | Anaplerotic role of pyruvate |
| LDH | Lactate dehydrogenase | Pyruvate metabolism |
| GOT1 | Aspartate aminotransferase | Links pyruvate to amino acid metabolism |
| MDH2 | Malate dehydrogenase | TCA cycle enzyme |
| SDHA | Succinate dehydrogenase | TCA cycle and mitochondrial function |
How Is acylpyruvate hydrolase activity Regulated?
Acylpyruvate hydrolase activity is regulated at multiple levels. Transcriptional regulation of FAHD1 is controlled by PGC-1α, a master regulator of mitochondrial biogenesis, linking the enzyme's expression to cellular energy demands. Post-translational modifications, particularly acetylation, modulate FAHD1 enzymatic activity; SIRT3-mediated deacetylation may enhance its acylpyruvate hydrolase function. Additionally, substrate availability influences flux through the reaction, as the enzyme competes with other pyruvate-consuming pathways. In bacteria, the expression of acylpyruvate hydrolases is often induced by specific aromatic substrates, ensuring timely degradation.
acylpyruvate hydrolase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| FAHD1 | Cancer metabolism, mitochondrial dysfunction | CRISPR knockout in cancer cell lines |
| FAHD1 | Aging and oxidative stress | Mouse knockout models |
| FAHD1 | Metabolic reprogramming | Overexpression in HEK293 cells |
| HpcE | Bacterial aromatic degradation | Bacterial knockout and complementation |
| L-DDRA | L-rhamnose metabolism | Enzyme assays and structural studies |
Cancer Metabolism
FAHD1, the human acylpyruvate hydrolase, has been implicated in cancer metabolism. Its bi-functional role in oxaloacetate decarboxylation and acylpyruvate hydrolysis affects the availability of pyruvate and TCA cycle intermediates, which are crucial for tumor growth. Altered FAHD1 expression has been observed in various cancers, suggesting it may serve as a metabolic biomarker or therapeutic target. Knockdown of FAHD1 in cancer cell lines leads to reduced proliferation and increased sensitivity to metabolic stress, highlighting its potential as an anticancer target.
Mitochondrial Dysfunction and Aging
FAHD1 is a mitochondrial protein, and its dysfunction is associated with mitochondrial impairments observed in aging and age-related diseases. Reduced acylpyruvate hydrolase activity may lead to the accumulation of acylpyruvate intermediates, causing oxidative stress and mitochondrial damage. Studies in mouse models have shown that FAHD1 deficiency results in altered mitochondrial morphology and function, contributing to premature aging phenotypes. These findings suggest that maintaining acylpyruvate hydrolase activity is important for mitochondrial health and longevity.
Inherited Metabolic Disorders
Deficiencies in enzymes involved in pyruvate metabolism, including acylpyruvate hydrolase, can lead to inherited metabolic disorders. Although no specific human disease has been directly linked to FAHD1 mutations, its role in tyrosine degradation pathways suggests that defects could contribute to conditions like tyrosinemia. In bacteria, acylpyruvate hydrolases are involved in the degradation of aromatic compounds, and their absence can lead to the accumulation of toxic intermediates. Understanding these pathways may inform the development of therapies for related metabolic diseases.
From acylpyruvate hydrolase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does FAHD1 knockout affect mitochondrial respiration? | CRISPR KO in HeLa or HEK293 cells |
| What is the effect of FAHD1 point mutations on catalysis? | Point mutation knock-in via CRISPR |
| Can FAHD1 overexpression rescue metabolic stress? | Overexpression in cancer cell lines |
| How does FAHD1 acetylation regulate activity? | Knock-in of acetylation mimics |
| What is the role of bacterial acylpyruvate hydrolase in aromatic degradation? | Bacterial KO and growth assays |
| Does FAHD1 interact with other metabolic enzymes? | Tagged knock-in for proteomics |
How to Study the acylpyruvate hydrolase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Enzymatic assay | Hydrolysis of 3-acylpyruvate to pyruvate | Kinetic characterization |
| X-ray crystallography | Three-dimensional structure | Active site and mechanism |
| CRISPR KO | Loss of function | Metabolic and proliferation studies |
| CRISPR knock-in | Point mutations | Catalytic residue analysis |
| Overexpression | Gain of function | Rescue and stress response |
| RNA-seq | Transcriptional changes | Pathway identification |
| Proteomics | Protein interactions and modifications | Acetylation and complex formation |
| Metabolic flux analysis | Flux through pyruvate | Cancer metabolism |
Enzymatic Activity Assays
Direct measurement of acylpyruvate hydrolase activity is performed using spectrophotometric or chromatographic assays. Typically, the hydrolysis of a 3-acylpyruvate substrate is monitored by the formation of pyruvate, which can be coupled to lactate dehydrogenase and NADH oxidation at 340 nm. Alternatively, HPLC or LC-MS can quantify substrate depletion and product formation. These assays are essential for characterizing enzyme kinetics, substrate specificity, and the effects of mutations.
Structural Biology
X-ray crystallography and cryo-EM have been used to determine the three-dimensional structures of acylpyruvate hydrolases, such as FAHD1 and L-DDRA. These structures reveal the active site architecture, catalytic residues, and metal coordination, providing insights into the mechanism. Site-directed mutagenesis combined with structural analysis can identify key residues for catalysis and substrate binding. Structural studies also facilitate the design of specific inhibitors.
CRISPR-Based Functional Genomics
CRISPR-Cas9 knockout screens are powerful tools to study the cellular roles of acylpyruvate hydrolase activity. By generating FAHD1 knockout cell lines, researchers can assess changes in metabolism, proliferation, and stress responses. Knock-in of point mutations allows precise dissection of catalytic residues in vivo. Overexpression models can test gain-of-function effects and rescue experiments. These approaches are complemented by RNA-seq and proteomics to identify downstream pathways.
Metabolic Flux Analysis
Stable isotope tracing with 13C-labeled substrates combined with mass spectrometry can quantify metabolic fluxes through acylpyruvate hydrolase. This method measures the contribution of the enzyme to pyruvate production and TCA cycle anaplerosis. Flux analysis in knockout versus wild-type cells reveals the metabolic rewiring that occurs upon loss of activity. Such studies are critical for understanding the enzyme's role in cancer and metabolic disorders.
How CRISPR Can Be Used to Study GO:0047621 acylpyruvate hydrolase activity
Knockout
CRISPR-Cas9 knockout of FAHD1 is used to create cell lines completely lacking acylpyruvate hydrolase activity. These models have revealed that FAHD1 loss leads to reduced mitochondrial respiration and increased sensitivity to oxidative stress. Knockout cells also show altered levels of TCA cycle intermediates, confirming the enzyme's role in pyruvate homeostasis. Such models are valuable for studying the metabolic dependencies of cancer cells and for identifying synthetic lethal interactions.
Point Mutation
Point mutations in the catalytic residues of FAHD1 (e.g., Ser, His, Asp) can be introduced via CRISPR knock-in to dissect the enzymatic mechanism. For example, mutation of the nucleophilic serine abolishes acylpyruvate hydrolase activity while potentially preserving structural integrity. These models help distinguish between catalytic and non-catalytic functions of the protein. They are also useful for validating inhibitor specificity.
Knock-in
Knock-in of tagged FAHD1 (e.g., FLAG, HA, or GFP) allows for affinity purification and localization studies. Tagged knock-in cell lines enable the identification of interaction partners and post-translational modifications under near-physiological conditions. Additionally, knock-in of disease-associated mutations can model their effects on enzyme activity and mitochondrial function. These models are essential for understanding the regulation of acylpyruvate hydrolase in its native context.
Overexpression
Overexpression of wild-type or mutant FAHD1 in cell lines is used to study gain-of-function effects. Overexpression can rescue phenotypes observed in knockout cells and provide insights into the enzyme's role in metabolic reprogramming. It also facilitates the production of recombinant protein for structural and biochemical studies. However, careful controls are needed to avoid artifacts from supraphysiological expression levels.
How EDITGENE Supports acylpyruvate hydrolase activity Research
Researchers studying acylpyruvate hydrolase activity-related genes often need to determine whether a candidate gene is causally involved in metabolic pathways, disease progression, or drug response. EDITGENE provides a comprehensive suite of CRISPR-based services to accelerate this research, from gene knockout to precise point mutations and library screening.
Contact EDITGENE today to design your custom CRISPR model for acylpyruvate hydrolase activity research.
Frequently Asked Questions About acylpyruvate hydrolase activity
What is acylpyruvate hydrolase activity?
Acylpyruvate hydrolase activity (GO:0047621) is a molecular function that catalyzes the hydrolysis of a 3-acylpyruvate into a carboxylate and pyruvate.
What genes are involved in acylpyruvate hydrolase activity?
The primary human gene is FAHD1, which encodes a mitochondrial acylpyruvase. Bacterial homologs include L-DDRA and HpcE.
What is the role of FAHD1 in cancer?
FAHD1 is involved in metabolic reprogramming and its altered expression is associated with cancer progression, making it a potential therapeutic target.
How is acylpyruvate hydrolase activity regulated?
It is regulated transcriptionally by PGC-1α and post-translationally by acetylation, which modulates enzymatic activity.
What diseases are linked to acylpyruvate hydrolase deficiency?
Deficiency may contribute to mitochondrial dysfunction, aging, and metabolic disorders, though direct human diseases are not yet firmly established.
What methods are used to study acylpyruvate hydrolase activity?
Common methods include enzymatic assays, X-ray crystallography, CRISPR knockout/knock-in, and metabolic flux analysis.
Can CRISPR be used to study acylpyruvate hydrolase?
Yes, CRISPR knockout and knock-in models are powerful tools to dissect the function of FAHD1 and its role in metabolism.
What is the reaction catalyzed by acylpyruvate hydrolase?
The reaction is: a 3-acylpyruvate + H2O = a carboxylate + pyruvate.
Is acylpyruvate hydrolase activity found in bacteria?
Yes, bacterial enzymes such as L-DDRA and HpcE exhibit this activity and are involved in aromatic compound degradation.
What are the products of acylpyruvate hydrolase activity?
The products are pyruvate and a carboxylate.
Conclusion
Acylpyruvate hydrolase activity (GO:0047621) is a fundamental enzymatic function with critical roles in mitochondrial metabolism, bacterial degradation pathways, and disease. The human enzyme FAHD1 exemplifies the bi-functionality and regulatory complexity of this activity, linking it to cancer, aging, and metabolic disorders. Advances in CRISPR-based models and structural biology continue to unravel its mechanisms, offering new opportunities for therapeutic intervention. EDITGENE's comprehensive services empower researchers to explore this activity with precision and scale.
References
- 1. Weiss AKH et al.. 2018. Structural basis for the bi-functionality of human oxaloacetate decarboxylase FAHD1.. Biochem J 475(22):3561-3576 PMID: 30348641
- 2. Weiss AKH et al.. 2020. Structural and functional comparison of fumarylacetoacetate domain containing protein 1 in human and mouse.. Biosci Rep 40(3) PMID: 32068790
- 3. Fukuhara S et al.. 2023. Crystal Structure of l-2,4-Diketo-3-deoxyrhamnonate Hydrolase Involved in the Nonphosphorylated l-Rhamnose Pathway from Bacteria.. Biochemistry 62(2):524-534 PMID: 36563174
- 4. Pircher H et al.. 2011. Identification of human fumarylacetoacetate hydrolase domain-containing protein 1 (FAHD1) as a novel mitochondrial acylpyruvase.. J Biol Chem 286(42):36500-8 PMID: 21878618
- 5. Watson GK et al.. 1974. Microbial metabolism of the pyridine ring. The metabolism of pyridine-3,4-diol (3,4-dihydroxypyridine) by Agrobacterium sp.. Biochem J 140(2):277-92 PMID: 4375963
